Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOBENGUANE I-131 for Neuroblastoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 66 adverse event reports in the FDA FAERS database where IOBENGUANE I-131 was used for Neuroblastoma.

Most Reported Side Effects for IOBENGUANE I-131

Side Effect Reports % Deaths Hosp.
Neutropenia 25 20.3% 0 2
Disease progression 16 13.0% 3 3
Mucosal inflammation 15 12.2% 0 0
Thrombocytopenia 13 10.6% 2 1
Anaemia 12 9.8% 2 1
Product use in unapproved indication 11 8.9% 2 0
Platelet count decreased 8 6.5% 0 3
Febrile neutropenia 7 5.7% 1 3
Nausea 7 5.7% 0 3
Pyrexia 7 5.7% 0 4
Vomiting 7 5.7% 0 5
Drug ineffective 5 4.1% 0 1

Other Indications for IOBENGUANE I-131

Product used for unknown indication (27) Phaeochromocytoma (10) Paraganglion neoplasm (7)

Other Drugs Used for Neuroblastoma

CYCLOPHOSPHAMIDE (1,109) ETOPOSIDE (1,061) DOXORUBICIN (725) CARBOPLATIN (671) VINCRISTINE (668) CISPLATIN (633) MELPHALAN (495) TOPOTECAN (443) DINUTUXIMAB (354) BUSULFAN (252)

Related Pages

IOBENGUANE I-131 Full Profile All Neuroblastoma Drugs IOBENGUANE I-131 Demographics IOBENGUANE I-131 Timeline